On that sunny March morning, in a small health center in Lobamba, a rural area of Eswatini, this 32-year-old sex worker has just become one of the first people in the world to receive lenacapavir, a drug that, administered twice a year, offers nearly 100% protection against HIV.
"This argues for the need to sustain such policies and shows that it is possible to right the wrongs retroactively, which is a powerful idea," said Kenneth Michelson, MD, MPH, associate professor of Pediatrics in the Division of Emergency Medicine and a co-author of the study.
Kelly Chibale describes the drug discovery process as a fairy-tale quest, stating, 'It doesn't mean that there aren't surprises or miracles. They do happen, but you have to kiss many frogs before you meet the prince.' This metaphor illustrates the challenges and unpredictability in finding effective medicines.
Vick thought about a private blood fund run by one of her former employers and the many conversations she's had with other club members about how to support people with AIDS. A new thought emerged: What if Vick and her peers organized their own blood drive and created a fund for folks with AIDS to ensure their continued access?
The funds raised through Visionaries of the Year are used for research to advance lifesaving therapies like immunotherapy, genomics and personalized medicine, which are saving lives today.
Congress has kept key drug assistance funding at $900.3 million annually since 2014. New enrollments for state programs jumped 30% from 2022 to 2024, in part because states cut off pandemic-era Medicaid assistance. As of January, at least 18 states have pulled back their Ryan White AIDS Drug Assistance Programs, known as ADAPs, in some way.
Each day, they pore over reams of data about how the virus is evolving worldwide, how well last year's shot performed, and which strains might be easiest to mass produce for a vaccine. The meeting, convened by the World Health Organization twice a year, is a critical moment for the WHO's Global Influenza Surveillance and Response System.
For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of HIV. Each of these patients has experienced long-term viral control - in some cases for over a decade - without antiretroviral therapy (ART), as AIDSMap notes, though some doctors describe them as being in "remission." While the patients have shown no signs of HIV since stopping ART, at least some uncertainty remains as to whether the virus could eventually rebound in them.
Black people made up 48 percent of new HIV diagnoses in the South, but only 21 percent of PrEP users in the South; in the Midwest, Black people made up 48 percent of new HIV diagnoses, but only 12 percent of PrEP users. This regional disparity demonstrates the significant gap between HIV burden and preventive medication access among Black populations across different areas of the country.
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.Your support makes all the difference.
NPR's global health and development team tells stories about life in our changing world, focusing on low- and middle-income countries also referred to as the Global South. And we keep in mind that we're all neighbors in this global village. NPR receives financial support for this team from the Gates Foundation. NPR is solely responsible for all content. Find more about NPR's standards and practices at NPR.org/ethics, as well as a list of our philanthropic supporters in our annual report.
From the moment Nathaniel Dye was diagnosed with stage four bowel cancer in 2023, he had an overwhelming desire to raise awareness of the disease. He raised more than 37,000 for Macmillan Cancer Support through challenges including walking from Land's End to John o' Groats and running the London Marathon while playing the trombone, in the hope of improving cancer screening in the capital.
